|
Note 10 — Share-based compensation
The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
March 31, |
|
|
|
2020 |
|
2019 |
|
|
Research and development |
|
$ |
978 |
|
$ |
2,021 |
|
|
General and administrative |
|
|
470 |
|
|
1,458 |
|
|
|
|
$ |
1,448 |
|
$ |
3,479 |
|
|
The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
March 31, |
|
|
2020 |
|
2019 |
|
Number of options over ordinary shares granted |
|
|
10,229,280 |
|
|
10,807,200 |
|
Weighted average fair value of ordinary shares options |
|
$ |
0.51 |
|
$ |
0.55 |
|
Number of additional options with a nominal exercise price granted |
|
|
6,060,696 |
|
|
6,498,126 |
|
Weighted average fair value of options with a nominal exercise price |
|
$ |
0.74 |
|
$ |
0.94 |
|
|